Freedman RS - Search Results

1

14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients.

Kobayashi R, Deavers M, Patenia R, Rice-Stitt T, Halbe J, Gallardo S, Freedman RS. Kobayashi R, et al. Among authors: freedman rs. Cancer Immunol Immunother. 2009 Feb;58(2):247-58. doi: 10.1007/s00262-008-0549-7. Epub 2008 Jul 11. Cancer Immunol Immunother. 2009. PMID: 18618111 Free PMC article.

2

Migration deficit in monocyte-macrophages in human ovarian cancer.

Freedman RS, Ma Q, Wang E, Gallardo ST, Gordon IO, Shin JW, Jin P, Stroncek D, Marincola FM. Freedman RS, et al. Cancer Immunol Immunother. 2008 May;57(5):635-45. doi: 10.1007/s00262-007-0401-5. Epub 2007 Oct 10. Cancer Immunol Immunother. 2008. PMID: 17926037 Free PMC article.

3

HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.

Kooi S, Zhang HZ, Patenia R, Edwards CL, Platsoucas CD, Freedman RS. Kooi S, et al. Among authors: freedman rs. Cell Immunol. 1996 Dec 15;174(2):116-28. doi: 10.1006/cimm.1996.0301. Cell Immunol. 1996. PMID: 8954611

4

Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma.

Melichar B, Savary CA, Patenia R, Templin S, Melicharova K, Freedman RS. Melichar B, et al. Among authors: freedman rs. Int J Gynecol Cancer. 2003 Jul-Aug;13(4):435-43. doi: 10.1046/j.1525-1438.2003.13331.x. Int J Gynecol Cancer. 2003. PMID: 12911719

5

rIFN-gamma-mediated growth suppression of platinum-sensitive and -resistant ovarian tumor cell lines not dependent upon arginase inhibition.

Melichar B, Hu W, Patenia R, Melicharová K, Gallardo ST, Freedman R. Melichar B, et al. J Transl Med. 2003 Sep 19;1(1):5. doi: 10.1186/1479-5876-1-5. J Transl Med. 2003. PMID: 14572312 Free PMC article.

6

Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC).

Freedman RS, Deavers M, Liu J, Wang E. Freedman RS, et al. J Transl Med. 2004 Jun 25;2(1):23. doi: 10.1186/1479-5876-2-23. J Transl Med. 2004. PMID: 15219235 Free PMC article.

7

Comparative analysis of peritoneum and tumor eicosanoids and pathways in advanced ovarian cancer.

Freedman RS, Wang E, Voiculescu S, Patenia R, Bassett RL Jr, Deavers M, Marincola FM, Yang P, Newman RA. Freedman RS, et al. Clin Cancer Res. 2007 Oct 1;13(19):5736-44. doi: 10.1158/1078-0432.CCR-07-0583. Clin Cancer Res. 2007. PMID: 17908963

8

The expression of decorin in human ovarian tumors.

Nash MA, Deavers MT, Freedman RS. Nash MA, et al. Among authors: freedman rs. Clin Cancer Res. 2002 Jun;8(6):1754-60. Clin Cancer Res. 2002. PMID: 12060613

9

Development of a cell surface reacting human monoclonal antibody recognizing ovarian and certain other malignancies.

Freedman RS, Ioannides CG, Tomasovic B, Patenia R, Zhang HZ, Liang JC, Edwards CL. Freedman RS, et al. Hybridoma. 1991 Feb;10(1):21-33. doi: 10.1089/hyb.1991.10.21. Hybridoma. 1991. PMID: 2032733

10

Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin.

Apte SM, Vadhan-Raj S, Cohen L, Bassett RL, Gordon IO, Levenback CF, Ramirez PT, Gallardo ST, Patenia RS, Garcia ME, Iyer RB, Freedman RS. Apte SM, et al. Among authors: freedman rs. J Transl Med. 2006 Apr 7;4:16. doi: 10.1186/1479-5876-4-16. J Transl Med. 2006. PMID: 16603073 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters